Across TCGA pan-cancer cohorts, OR2B7P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR2B7P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where OR2B7P RNA is repressed in tumor relative to normal tissue. In most cancer types OR2B7P is over-expressed in tumor, although a few such as UCEC and THCA show the opposite, repressed pattern.

UCEC, THCA, and LUSC are the cancer types where OR2B7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR2B7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.091	.039	2	view →
THCA	All	All	−0.060	.024	2	view →
LUSC	Male	II,III,IV	−0.035	.025	2	view →
KIRP	All	All	−0.057	.021	1	view →
KICH	Male	All	−0.046	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: OR2B7P RNA expression & survival · all OR2B7P data types